DAPAS, BARBARA
 Distribuzione geografica
Continente #
NA - Nord America 8.664
EU - Europa 5.144
AS - Asia 1.803
AF - Africa 31
OC - Oceania 25
SA - Sud America 24
Continente sconosciuto - Info sul continente non disponibili 11
Totale 15.702
Nazione #
US - Stati Uniti d'America 8.604
IT - Italia 1.079
PL - Polonia 986
SE - Svezia 811
CN - Cina 633
DE - Germania 498
UA - Ucraina 496
HK - Hong Kong 405
SG - Singapore 398
RU - Federazione Russa 317
TR - Turchia 199
FI - Finlandia 188
GB - Regno Unito 172
FR - Francia 147
IE - Irlanda 124
BG - Bulgaria 122
BE - Belgio 50
CA - Canada 47
CH - Svizzera 36
IN - India 33
NL - Olanda 31
VN - Vietnam 29
AU - Australia 24
KR - Corea 23
SN - Senegal 17
BR - Brasile 16
JP - Giappone 16
TW - Taiwan 16
IR - Iran 15
MX - Messico 13
CZ - Repubblica Ceca 11
ES - Italia 11
EU - Europa 10
LU - Lussemburgo 9
AT - Austria 7
HR - Croazia 7
MY - Malesia 7
RS - Serbia 7
CL - Cile 6
EG - Egitto 6
GR - Grecia 6
NO - Norvegia 6
PK - Pakistan 6
RO - Romania 6
DK - Danimarca 5
IL - Israele 5
MO - Macao, regione amministrativa speciale della Cina 5
TH - Thailandia 4
ZA - Sudafrica 4
MU - Mauritius 3
PT - Portogallo 3
BD - Bangladesh 2
EE - Estonia 2
HU - Ungheria 2
MD - Moldavia 2
SA - Arabia Saudita 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AE - Emirati Arabi Uniti 1
AR - Argentina 1
BF - Burkina Faso 1
BO - Bolivia 1
ID - Indonesia 1
IQ - Iraq 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LT - Lituania 1
LV - Lettonia 1
NZ - Nuova Zelanda 1
SI - Slovenia 1
Totale 15.702
Città #
Ann Arbor 1.064
Warsaw 982
Woodbridge 969
Fairfield 834
Chandler 823
Houston 694
Ashburn 570
Jacksonville 468
Wilmington 396
Trieste 395
Hong Kong 394
Seattle 313
Singapore 301
Cambridge 287
Princeton 227
Boardman 218
Izmir 176
Beijing 157
Dearborn 139
Columbus 128
Dublin 120
Sofia 120
Moscow 113
Santa Clara 113
San Diego 47
Brussels 43
Redmond 40
Helsinki 38
Milan 38
Los Angeles 37
Duino-Aurisina 30
Bern 29
Padova 29
Redwood City 29
Düsseldorf 28
Washington 28
Kunming 26
Ottawa 26
Bremen 25
Jinan 23
Chicago 22
Shanghai 22
Phoenix 21
Grafing 20
Venezia 20
Nanjing 19
Seoul 19
Des Moines 18
Hefei 18
Dakar 17
Guangzhou 17
Verona 17
Dong Ket 16
Mestre 16
Norwalk 15
Dallas 14
Hebei 14
Falls Church 13
Fremont 13
Munich 13
Shenyang 13
Buffalo 12
Fuzhou 12
London 12
Nanchang 12
San Francisco 12
Kocaeli 11
Sydney 11
Taipei 11
Atlanta 10
Fagagna 10
Ho Chi Minh City 10
Pune 9
Rome 9
Udine 9
Wuhan 9
Zhengzhou 9
Dongguan 8
Indiana 8
Montreal 8
Venice 8
Bologna 7
Hangzhou 7
New York 7
Venustiano Carranza 7
Amsterdam 6
Chengdu 6
Ghent 6
Naples 6
Sacile 6
Salerno 6
Tianjin 6
Tokyo 6
Toronto 6
Wenzhou 6
Barcelona 5
Campinas 5
Central 5
Dudenhofen 5
Harbin 5
Totale 11.187
Nome #
Polysaccharides for the delivery of antitumor drugs 392
Polymer-mediated delivery of siRNAs to hepatocellular carcinoma: Variables affecting specificity and effectiveness 384
Potential applications of nanocellulose-containing materials in the biomedical field 375
GT75 aptamer against eukaryotic elongation factor 1A as potential anticancer drug for castrate-resistant prostate cancer (CRPC). 332
Therapeutic potential of small interfering RNAs/micro interfering RNA in hepatocellular carcinoma 311
Effect of cystic fibrosis sputum rheology on lungs drug delivery by inhalation 249
Therapeutic potential of Nucleic acid-based drugs in coronary hyper-proliferative vascular diseases 233
Strategies for delivery of siRNAs to ovarian cancer cells 225
Recent advances in smart biotechnology: Hydrogels and nanocarriers for tailored bioactive molecules depot 219
The role of the transcription factor E2F1 in hepatocellular carcinoma 218
Serum Response Factor depletion affects the proliferation of the hepatocellular carcinoma cells HepG2 and JHH6 215
Mathematical modeling of drug release from natural polysaccharides based matrices 215
Therapeutic potential and delivery strategies for nucleic acid-based drugs 208
Strategies to optimize siRNA delivery to hepatocellular carcinoma cells 201
Current strategies to improve the efficacy and the delivery of nucleic acid based drugs 191
Drug delivery from polymeric matrices 188
Novel Lipid and Polymeric Materials as Delivery Systems for Nucleic Acid Based Drugs 181
Translation Elongation 180
A novel approach based on low-field NMR for the detection of the pathological components of sputum in cystic fibrosis patients 172
"Human cancer cell lines growth inhibition by GTn oligodeoxyribonucleotides recognizing single stranded DNA-binding proteins" 171
Membranes in Drug Delivery 171
Aptameric GT oligomers need to be complexed to ethoxylated polyethylenimine as pre-paired duplexes to efficiently exert their cytotoxic activity in human lymphoblastic cancer cells 168
Bortezomib arrests the proliferation of hepatocellular carcinoma cells HepG2 and JHH6 by differentially affecting E2F1, p21 and p27 levels. 166
Dissecting the role of the elongation factor 1A isoforms in hepatocellular carcinoma cells by liposome-mediated delivery of siRNAs 164
Impairment of the Pin1/E2F1 axis in the anti-proliferative effect of bortezomib in hepatocellular carcinoma cells 162
Rapid and cost-effective xenograft hepatocellular carcinoma model in Zebrafish for drug testing 161
The expression levels of the translational factors eEF1A 1/2 correlate with cell growth but not apoptosis in hepatocellular carcinoma cell lines with different differentiation grade 160
Alcohol reduces MMP-2 in humans and isolated smooth muscle cells. 160
Aptamer targeting of the elongation factor 1A impairs hepatocarcinoma cells viability and potentiates bortezomib and idarubicin effects 158
Characterization of nucleic acid molecule/liposome complexes and rheological effects on pluronic/alginate matrices 158
Can low field nuclear magnetic resonance be used to monitor lung functionality of cystic fibrosis patients? 156
Dissecting the expression of EEF1A1/A2 genes in human prostate cancer cells: the potential od EEF1A2 as a hallmark for prostate transformation and progression 155
Comparison between recombinant baculo and adenoviral-vectors as transfer system in cardiovascular cells 150
null 150
Effects of E2F1-cyclinE1-E2 circuit down-regulation in hepatocellular carcinoma cells 148
null 148
Epigenetic and miRNAs dysregulation in prostate cancer: the role of nutraceuticals. 144
Improving siRNA Bio-Distribution and Minimizing Side Effects 142
A rapid and specific method to simultaneously quantify eukaryoticelongation factor 1A1 and A2 protein levels in cancer cells 142
In vitro and ex vivo delivery of tailored siRNA-nanoliposomes for E2F1 silencing as a potential therapy for colorectal cancer 141
Synthesis and Spontaneous Polymerization of Oligo(ethyleneglycol)-Conjugated Benzofulvene Macromonomers.A Polymer Brush Forming a Physical Hydrogel 140
Diagnostic and prognostic role of eEF1A in chronic lymphocytic leukaemia 139
Aptamers as nano-targeting delivery devices or anti-cancer drugs for fighting tumours 137
null 136
null 136
Galactosylated polyaspartamide copolymers for siRNA targeted delivery to hepatocellular carcinoma cells 136
Potential applications of small interferring RNA in the cardiovascular field 132
Novel hepatocellular carcinoma molecules with prognostic and therapeutic potentials 132
Characterisation of nucleid acid molecule/liposome complexes and rheological effects on pluronic/alginate matrices 129
Proliferation of human primary vascular smooth muscle cells depends on serum response factor. 128
Effects of hypoxia and bed rest on markers of cardiometabolic risk: Compensatory changes in circulating trail and glutathione redox capacity 127
A siRNA targeted against SRF reduce hepatocellular carcinoma cell proliferation, showing its potential use in the growth inhibition of this type of tumor 126
E2F1 as a molecular drug target in ovarian cancer 123
null 121
A siRNA targeted against SRF reduce hepatocellular carcinoma cell proliferation, showing its potential use in the growth inhibition of this type of tumor 121
Synthesis and characterization of polyaspartamide copolymers obtained by ATRP for nucleic acid delivery 121
Can rheology be useful in the cystic fibrosis frame 120
null 119
Propaedeutic study for the delivery of nucleic acid-based molecules from PLGA microparticles and stearic acid nanoparticles 119
Hydrogels mesh size evaluation 117
Evaluation of the contribution of the elongational factor 1 A isoforms in hepatocellular carcinoma celss growth 116
"Charactherization of nucleic acid molecule/liposome complexes and rheological effects on pluronic/alginate matrices" 115
The Role of the eEF1A Family in Human Cancers 115
Use of Rheology and portable Low-Field NMR for the monitoring of lung functions in cystic fibrosis patients 114
Uso di small interfering RNA (SIRNA) per il trattamento di patologie caratterizzate da iperproliferazione cellulare 113
“Alpha-anomeric configuration of GT oligodeoxynucleotide leads to loss of specific aptameric and cytotoxic properties retained by the Beta-anomeric analog” 113
Development of a simple, biocompatible and cost-effective Inulin-Diethylenetriamine based siRNA delivery system 113
PDPG Polymer as a targeted delivery system for siRNAs to hepatocellular carcinoma cells 113
“The expression levels of the translational factors eEF1A1/2 correlate with the cell growth but not apoptosis in hepatocellular carcinoma cell lines with different differentiation grade” 112
SiRNAs targeted against cyclin E1, cyclin E2 and E2F1 down regulate the growth of Hepatocellular Carcinoma showing their potential use in the prevention of this type of tumor 112
Cyclin E1, E2 and E2F1 targeted siRNAs down regulate the growth of coronary smooth muscle cell, thus showing their potential use in the prevention of in-stent restenosis 112
Effects of eEF1A1 targeting by aptamer/siRNA in chronic lymphocytic leukaemia cells 111
null 111
“Can TIE-2 expressing monocytes represent a novel marker for Hepatocellular Carcinoma? 110
Drug delivery and mathematical modeling: an historical perspective 110
SIMPLE, BIOCOMPATIBLE AND COST-EFFECTIVE INULIN BASED siRNA DELIVERY SYSTEMS 108
The targeting of the elongation factor 1A by a DNA aptamer impairs the viability of hepatocarcinoma cells 107
Role of E2F1-cycline1-cycline2 circuit in hepatocellular carcinoma cell proliferation and therapeutic potential of its down-regulation by siRNAs 105
SCHS SMART CREAM FOR A HEALTY SKIN 101
“Increase in therapeutic index of doxorubicin and vinblastine by aptameric oligonucleotide in human T-lymphoblastic drug sensitive and multidrug-resistance cells” 100
“ Identification of different isoforms of eEF1A in the nuclear fraction of human T-lymphoblastic cancer cell lines specifically binding to aptameric cytotoxic GT oligonucleotides” 99
null 98
Effects of various promoter derived sequences on the cleavage kinetic of an hammerhead ribozyme directed against cyclin E1 mRNA. 97
Evaluation of bortezomib impact on cell-cycle related genes in the hepatocellular carcinoma cell lines hepg2 and jhh6 by means of microarray analysis 93
Potential Application Of Proteasome Inhibitor Bortezomib For Treatment Of Hepatocellular Carcinoma 93
Potential Application Of Proteasome Inhibitor Bortezomib For the Treatment Of Hepatocellular Carcinoma 91
Use of low field nuclear magnetic resonance to monitor lung inflammation and the amount of pathological components in the sputum of cystic fibrosis patients 91
Identification of nuclear elongation factor 1 alpha as single-stranded DNA-binding protein specifically recognising GT oligodeoxynucleotides that exert a selective human cancer cell growth inhibition 89
USO SINERGICO DELLA REOLOGIA E DELLA RISONANZA MAGNETICA NUCLEARE A BASSO CAMPO PER CARATTERIZZARE L’ESPETTORATO DI PAZIENTI CON FIBROSI CISTICA 88
Combined use of rheology and portable low-field NMR in cystic fibrosis patients 87
Effect of oligomer length and base substitutions on the cytotoxic activity and specific nuclear protein recognition of GTn oligonucleotides in the human leukemic CCRF-CEM cell line.” 86
Effect of chest physiotherapy on cystic fibrosis sputum nanostructure: an experimental and theoretical approach 86
Aptamers as targeting delivery devices or anti-cancer drugs for fighting tumors 83
High eEF1A1 Protein Levels Mark Aggressive Prostate Cancers and the In Vitro Targeting of eEF1A1 Reveals the eEF1A1–Actin Complex as a New Potential Target for Therapy 83
Xenograft zebrafish models for the development of novel anti-hepatocellular carcinoma molecules 82
“Effect of phosphorotioate modifications on the GTn oligodeoxynucleotide ability to recognise the single stranded DNA binding proteins specifically related to the human cancer cellular growth inhibition” 81
Ethoxylated polyethylenimine successfully enhances the cytotoxic activity of GT oligomers targeted to specific nuclear proteins in human T-Lymphoblastic cancer cells. 80
The more basic isoform of eEF1A relates to tumour cell phenotype and is modulated by hyper-proliferative/differentiating stimuli in normal lymphocytes and CCRF-CEM T-lymphoblasts 80
Role of E2F1–Cyclin E1-Cyclin E2 Circuit in Human Coronary Smooth Muscle Cell Proliferation and Therapeutic Potential of Its Downregulation by siRNAs 79
Hydrogel mesh size evaluation 79
Totale 14.479
Categoria #
all - tutte 45.390
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 45.390


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.369 0 0 0 0 0 0 364 321 240 165 193 86
2020/20211.721 173 102 146 256 144 158 89 141 86 203 56 167
2021/20221.568 58 96 59 203 39 125 77 76 140 151 190 354
2022/20232.434 228 334 234 338 218 365 38 214 263 45 107 50
2023/20241.455 79 85 86 86 162 158 192 279 21 103 102 102
2024/20251.346 27 93 214 251 308 314 139 0 0 0 0 0
Totale 16.167